INTEROJO CO. LTD. Logo

INTEROJO CO. LTD.

A global manufacturer and marketer of hydrogel and silicone hydrogel contact lenses.

119610 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 평택시 산단로15번길 28, 평택시
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Established in 2000, Interojo Inc. is a specialized manufacturer and marketer of contact lenses. The company develops, produces, and sells a variety of vision care products, including silicone hydrogel, premium hydrogel, and hydrogel lenses for both domestic and international markets. Operating under the mission to be 'The Best Vision Care Partner,' Interojo leverages its own technologies to provide a portfolio of contact lens products and related services. Its offerings are marketed under brands such as Clalen.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Capital/Financing Update
교환사채(해외교환사채포함)발행후만기전사채취득 (제4회차)
Korean 8.9 KB
2025-09-19 00:00
Transaction in Own Shares
[기재정정]주요사항보고서(자기주식처분결정)
Korean 33.2 KB
2025-09-19 00:00
Transaction in Own Shares
[기재정정]자기주식처분결과보고서
Korean 43.9 KB
2025-09-10 00:00
Related Party Transaction
임원ㆍ주요주주특정증권등거래계획철회보고서
Korean 20.3 KB
2025-08-21 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 28.0 KB
2025-08-21 00:00
Regulatory News Service
신탁계약해지결과보고서
Korean 31.0 KB
2025-08-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 170.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-13 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 45.7 KB
2025-08-06 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.8 KB
2025-08-06 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 170.1 KB
2025-08-04 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.8 KB
2025-07-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.8 KB
2025-07-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB

Automate Your Workflow. Get a real-time feed of all INTEROJO CO. LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for INTEROJO CO. LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Neola Medical AB Logo
Develops a medical device for continuous, non-invasive lung monitoring of preterm infants.
Sweden NEOLA
NEXTBIOMEDICAL Co., Ltd. Logo
Develops polymer-based drug-device solutions for hemostasis and drug delivery worldwide.
South Korea 389650
Manufacturer of industrial pumps, aerospace parts, and blood purification medical devices.
Japan 6376
NIOX GROUP PLC Logo
Develops point-of-care devices for FeNO testing to help manage asthma and airway inflammation.
United Kingdom NIOX
NIPRO CORPORATION Logo
Global manufacturer of renal care devices, injectable drugs, and pharmaceutical packaging.
Japan 8086
Israel NISA
Noble M&B Co., Ltd. Logo
Manufactures precision optics for auto/projectors and develops biotech diagnostic products.
South Korea 106520
NOSA Plugs AB Logo
Develops intranasal products for odor control, allergy relief, and smell recovery for B2C/B2B.
Sweden NOSA
Noul Co., Ltd. Logo
AI-powered, automated point-of-care diagnostics for accessible global healthcare.
South Korea 376930
ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. Logo
Manufactures automated systems & devices for safe, efficient oncology chemotherapy treatment.
Türkiye ONCSM

Talk to a Data Expert

Have a question? We'll get back to you promptly.